These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 376739)

  • 1. Single mouse cells producing two antibody molecules and giving rise to antigen-driven intraclonal variation after immunization with two unrelated antigens.
    Couderc J; Bleux C; Ventura M; Liacopoulos P
    J Immunol; 1979 Jul; 123(1):173-81. PubMed ID: 376739
    [No Abstract]   [Full Text] [Related]  

  • 2. The potentiality of antibody-producing cells. II. Evidence for two antibody molecules of different specificities secreted by micromanipulated bispecific mouse spleen cells.
    Couderg J; Bleux C; Liacopoulos P
    Immunology; 1975 Oct; 29(4):665-74. PubMed ID: 52617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient appearance of cells secreting antibody of different specificities after immunization of mice with trinitrophenylated erythrocytes.
    Couderc J; Bleux C; Birrien JL; Liacopoulos P
    J Immunol; 1973 Oct; 111(4):1155-63. PubMed ID: 4580665
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vivo primary response to 2,4,6-trinitrophenyl substituted erythrocytes.
    Pazdernik TL; Uyeki EM
    Immunology; 1973 May; 24(5):823-30. PubMed ID: 4577080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hapten antibody in primary immune antiserum can specifically inhibit antibody-secreting cells.
    Woodland RT; Zimmerman DM; Schrater AF
    J Immunol; 1982 Nov; 129(5):2009-15. PubMed ID: 6749983
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production of antibodies with 2 specificities by individual mouse cells].
    Liacopoulos P; Couderc J; Bleux C; Birrien JL
    Ann Immunol (Paris); 1974 Jan; 125C(1-2):267-70. PubMed ID: 4142555
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamin A: adjuvant and steroid antagonist in the immune response.
    Cohen BE; Cohen IK
    J Immunol; 1973 Nov; 111(5):1376-80. PubMed ID: 4583075
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunology of the lower respiratory tract. II. The plaque-forming response of canine lymphoid tissues to sheep erythrocytes after intrapulmonary or intravenous immunization.
    Kaltreider HB; Kyselka L; Salmon SE
    J Clin Invest; 1974 Aug; 54(2):263-70. PubMed ID: 4603168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of BCG on antibody producing mouse cells].
    Gryschek G
    Allerg Immunol (Leipz); 1973; 19(2-4):163-5. PubMed ID: 4281617
    [No Abstract]   [Full Text] [Related]  

  • 10. T cell-dependent mediator in the immune response. III. The role of non-specific factor (NSF) in the in vitro immune response.
    Waldmann H
    Immunology; 1975 Mar; 28(3):497-507. PubMed ID: 1092612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of different doses of antigen in primary immunization on formation of PFC and RFC in the primary and secondary responses.
    Halasa J; Podkowińska I; Braun J; Fidorowicz D
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):709-14. PubMed ID: 4589298
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the control of antibody synthesis. VII. Change in affinity of direct and indirect plaque-forming cells with time after immunization in the mouse: loss of high affinity plaques late after immunization.
    Goidl EA; Barondess JJ; Siskind GW
    Immunology; 1975 Oct; 29(4):629-41. PubMed ID: 52616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells involved in the immune response. XXIV. The demonstration of the multiclonal nature of the antigen-reactive cell population in the bone marrow of the normal adult rabbit.
    Richter M; Abdou NI
    J Immunol; 1971 Sep; 107(3):903-5. PubMed ID: 4937188
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for multipotentiality of antibody synthesizing cells.
    Liacopoulos P; Couderc J; Bleux C
    Ann Immunol (Paris); 1976; 127(3-4):519-30. PubMed ID: 786144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carrier priming on antibody avidity in the in vivo and in vitro immune response.
    Doria G; Agarossi G; Boraschi D; Antonietta M
    Immunology; 1977 Apr; 32(4):539-48. PubMed ID: 344202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional symmetry amongst daughter cells arising in vitro from single antibody-forming cells.
    Nossal GJ; Lewis H
    Immunology; 1971 May; 20(5):739-53. PubMed ID: 4950858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular requirements for development of primary anti-hapten antibody responses in vitro.
    Bluestein HG; Pierce CW
    J Immunol; 1973 Jul; 111(1):137-42. PubMed ID: 4123367
    [No Abstract]   [Full Text] [Related]  

  • 18. A mechanism for the unresponsive state in BALB-c mice after repeated doses of sheep erythrocytes.
    Thomson PD; Jutila JW
    J Immunol; 1972 Oct; 109(4):742-8. PubMed ID: 4627508
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of preimmunization with its carrier on the cellular secretion of IgM anti-TNP antibodies].
    Iannello D; Mancini C; Doria G
    G Batteriol Virol Immunol; 1981; 74(7-12):229-38. PubMed ID: 6751913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steps in the primary immune response in vivo. I. The repeated requirement for antigen (author's transl)].
    Albers P; Gilsenbach H
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1974; 69():1-9. PubMed ID: 4596477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.